STOCK TITAN

10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

10x Genomics (Nasdaq: TXG) announced participation in the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 2:15 p.m. ET. The presentation will be accessible via a live and archived webcast on the company's website. 10x Genomics specializes in life science technology, offering integrated solutions for biological analysis.

Its products are utilized globally, including by top research institutions and pharmaceutical companies. The company boasts over 1,200 patents and has contributed to significant research in areas like oncology and neuroscience.

Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., Dec. 22, 2021 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

10x Genomics' management is scheduled to present virtually on Monday, January 10, at 2:15 p.m. Eastern Time / 11:15 a.m. Pacific Time.  Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Media Contact:
media@10xgenomics.com

Investor Relations Contact:  
investors@10xgenomics.com

10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-virtually-at-the-40th-annual-jp-morgan-healthcare-conference-301450093.html

SOURCE 10x Genomics, Inc.

FAQ

What date will 10x Genomics present at the J.P. Morgan Healthcare Conference?

10x Genomics will present on January 10, 2022.

What time is the 10x Genomics presentation at the conference?

The presentation is scheduled for 2:15 p.m. Eastern Time.

Where can I watch the 10x Genomics presentation?

The presentation will be available via a live and archived webcast on 10x Genomics' website.

What is 10x Genomics known for?

10x Genomics is known for its advanced solutions in life science technology, particularly in biological analysis.

How many patents does 10x Genomics hold?

10x Genomics holds over 1,200 issued patents and patent applications.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

1.80B
107.00M
2.17%
94.13%
6.32%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
PLEASANTON